R Speaks NLME (RsNLME)
Download the brochure to learn more about RsNLME’s features and benefits.
CertaraMarch 9, 2021
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors
It is crucial for biotech developers to engage in early commercial market assessment to generate…
CertaraMarch 5, 2021
Scientific Computing World: Connecting Science
Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…
CertaraMarch 4, 2021
Controlled Terminology Best Practices
Simplify Controlled Terminology with expert insights from Sarah Angelo. Overcome challenges, ensure compliance, and improve…
CertaraMarch 3, 2021
Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software
In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…
CertaraMarch 2, 2021
Quantitative Systems Pharmacology for Drug Discovery and Development
Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…
CertaraMarch 2, 2021
Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe
Broadens European footprint with integrated regulatory services and statistical analysis PRINCETON, NJ.— March 2, 2021–…
CertaraMarch 2, 2021
The Importance of Continuity of Operations Plans for Gene Therapy Manufacturers
By: James Zoshak The COVID-19 pandemic has added increased risk and uncertainty to gene therapy…
CertaraFebruary 22, 2021
